HomeDFTX • NASDAQ
add
Definium Therapeutics Inc
Nakaraang pagsara
$17.18
Sakop ng araw
$16.55 - $17.95
Sakop ng taon
$14.62 - $18.69
Market cap
1.73B USD
Average na Volume
1.71M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 47.58M | 46.57% |
Net na kita | -50.44M | -45.18% |
Net profit margin | — | — |
Kita sa bawat share | -0.50 | -21.95% |
EBITDA | -47.45M | -46.16% |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 411.59M | 50.36% |
Kabuuang asset | 440.10M | 45.66% |
Kabuuang sagutin | 107.77M | 77.54% |
Kabuuang equity | 332.33M | — |
Natitirang share | 99.70M | — |
Presyo para makapag-book | 5.11 | — |
Return on assets | -35.14% | — |
Return on capital | -43.69% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -50.44M | -45.18% |
Cash mula sa mga operasyon | -42.98M | -69.52% |
Cash mula sa pag-invest | 34.98M | — |
Cash mula sa financing | 245.87M | 6,358.31% |
Net change in cash | 237.88M | 1,204.20% |
Malayang cash flow | -24.10M | -63.78% |
Tungkol
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs. Wikipedia
Itinatag
2010
Website
Mga Empleyado
105
